HOME >> MEDICINE >> NEWS
Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium

and public health experts are included on the program for the April 11 and 12 symposium, "Remembering Polio: The History and Future of Vaccine Development."

In some ways, the fear of polio was as terrifying as the disease itself, with parents overprotecting their children and communities shutting down public venues. When the epidemic in the United States peaked in 1952, polio had struck nearly 58,000 people--mainly children and young adults. The most critically ill were confined to a mechanical ventilator known as an iron lung, robbed of their ability to breathe on their own. Others escaped on crutches, crippled but not paralyzed. Panic was pandemic. It is almost impossible to exaggerate the terror that polio caused at the time.

The initial breakthrough that led to the eventual eradication of polio throughout most of the world is credited to Dr. Salk and his Pitt team of researchers, who developed the first polio vaccine. It was Salk's mentor, Thomas Francis, Jr., of the University of Michigan, who led the nationwide clinical trial of the vaccine that began April 26, 1954, and ended with the greatly anticipated announcement of its results on April 12 the next year. The day was heralded by dramatic headlines, ringing church bells and celebrations that spilled into the streets.

Following is additional information about each event.
Remembering Polio: A Tribute to Pittsburgh's Own Polio Pioneers
Sunday, April 10, 5 7 p.m., University of Pittsburgh Cathedral of Learning Commons Room

Stacy Smith, KDKA-TV anchor and polio survivor, will emcee the event that features Hollywood legend Mickey Rooney; Tenley Albright, M.D., a Harvard University surgeon and researcher who, despite a childhood bout with polio, went on to become a champion figure skater and, in the 1956 Olympics, the first American woman to win a gold medal in her sport; Peter L. Salk, M.D., vice president and scientific director of the Jonas Salk Foundation and t
'"/>


29-Mar-2005


Page: 1 2 3 4 5

Related medicine news :

1. Dairy Council of California program receives high marks from teachers & students
2. Surgery without the scapel: U. Va. Health System marks fifteenth anniversary of Gamma knife
3. MRI improves treatment of deforming birthmarks
4. Bite-marks giving false impression
5. Physicians not easy marks for drug sales reps, argues O.R. study
6. Survey: Medicare gets higher marks from enrollees than private insurance
7. Birthmarks best treated with red laser light
8. Chemical & Engineering News 80th anniversary issue highlights periodic table
9. NIAID releases 20th anniversary edition of Jordan Report on vaccine research
10. Change in polio vaccine policy eliminates cases of vaccine-associated polio in US
11. Researchers use crippled poliovirus to attack brain cancer

Post Your Comments:
(Date:8/1/2015)... ... ... and Lita Hart, icons of the network marketing industry and founders of the Healthy ... Movement of EvolvHealth. In what has been a long-term relationship between the companies for ... of purpose together to change the course of the network marketing industry. , “This ...
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... message including ones already sent. , While text messaging has more features than it ...
(Date:7/31/2015)... ... ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened a ... July 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and Latin ... Nursing and Allied Health Personnel Development, Unit of Human Resources for Health, Department of ...
(Date:7/31/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... introduced its new store run by GoodThreads. The store can be accessed by ... and designs, many of which are customizable. The best part: whenever a product ...
(Date:7/31/2015)... Meadows, IL (PRWEB) , ... July 31, 2015 ... ... ways to communicate. Rally Insurance Group, Inc. has re-branded their social media profiles ... provides a personal way for consumers to communicate, find information, share insights and ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
(Date:7/31/2015)... LAKE, N.J. and SAN DIEGO ... today that its parent company Eisai Co., Ltd. (Headquarters: ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... CEO: Dr. Helen Torley , "NASDAQ: HALO") have ... mesylate (brand name: Halaven ® , "eribulin") in combination ...
(Date:7/30/2015)... July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... valves and hemodynamic monitoring, today announced that Robert A. ... "Bob is an ardent champion for innovation in ... to have him on Edwards, board as we pursue our ... chairman and CEO.  "Bob has provided a valuable perspective to ...
(Date:7/30/2015)...  ResMed Inc. (NYSE: RMD ) today announced ... for the quarter was $453.1 million, a 9 percent ... (a 17 percent increase on a constant currency basis). ... ended June 30, 2014.  Diluted earnings per share for ... June 30, 2014.  The results for ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
Cached News: